Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

UT961

Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores
Unstained: $185.00 Add to Cart
H&E (UT961s*): $185.00 Add to Cart

Microarray Panel:Endometrial endometrioid adenocarcinoma tissue microarray, containing 32 cases of endometrium endometrioid adenocarcinoma, 1 each of endometrium adenosquamous carcinoma, carcinosarcoma, stromal sarcoma, malignant mixed Mullerian Tumor and polyp, 2 each of endometrium adenomyosis and simple hyperplasia, 4 proliferative endometrium, plus 3 normal endometrium tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
B Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
C Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
D Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
E Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
F Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
G Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
H Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Marked point
Legend: Ute - Uterus

- Hyperplasia, - Malignant tumor, - Malignant tumor (stage IB), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Normal tissue, - Polyp

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 60 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A2 2 F 51 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A3 3 F 42 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
A4 4 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
A5 5 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A6 6 F 58 Uterus Endometrioid adenocarcinoma (sparse) 1 Ia T1aN0M0 Malignant
A7 7 F 65 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A8 8 F 64 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A9 9 F 63 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
A10 10 F 63 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
A11 11 F 46 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
A12 12 F 62 Uterus Endometrioid adenocarcinoma 2 IIIc T1cN1M0 Malignant
B1 13 F 60 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
B2 14 F 51 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
B3 15 F 42 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
B4 16 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
B5 17 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
B6 18 F 58 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B7 19 F 65 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B8 20 F 64 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B9 21 F 63 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
B10 22 F 63 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
B11 23 F 46 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
B12 24 F 62 Uterus Endometrioid adenocarcinoma 2 IIIc T1cN1M0 Malignant
C1 25 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C2 26 F 67 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C3 27 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C4 28 F 72 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C5 29 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C6 30 F 55 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C7 31 F 54 Uterus Adenocarcinoma (sparse) 2 Ib T1bN0M0 Malignant
C8 32 F 57 Uterus Adenocarcinoma (sparse) 2 Ib T1bN0M0 Malignant
C9 33 F 49 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
C10 34 F 60 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
C11 35 F 67 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
C12 36 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D1 37 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D2 38 F 67 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D3 39 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D4 40 F 72 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D5 41 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D6 42 F 55 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D7 43 F 54 Uterus Endometrioid adenocarcinoma (smooth muscle) – Ib T1bN0M0 Malignant
D8 44 F 57 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
D9 45 F 49 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
D10 46 F 60 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
D11 47 F 67 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
D12 48 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E1 49 F 56 Uterus Endometrioid adenocarcinoma 2–3 Ib T1bN0M0 Malignant
E2 50 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
E3 51 F 68 Uterus Endometrioid adenocarcinoma with necrosis (sparse) 3 Ib T1bN0M0 Malignant
E4 52 F 48 Uterus Endometrioid adenocarcinoma with necrosis 3 III T3N0M0 Malignant
E5 53 F 74 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
E6 54 F 44 Uterus Endometrioid adenocarcinoma with necrosis (sparse) 3 Ib T1bN0M0 Malignant
E7 55 F 58 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
E8 56 F 35 Uterus Endometrioid adenocarcinoma 3 IIIa T3N0M0 Malignant
E9 57 F 67 Uterus Adenosquamous carcinoma – IIa T2aN0M0 Malignant
E10 58 F 54 Uterus Carcinosarcoma – Ib T1bN0M0 Malignant
E11 59 F 26 Uterus Low grade endometrial stromal sarcoma – IB T2N0M0 G1 Malignant
E12 60 F 60 Uterus Malignant mixed Mullerian Tumor – IB T2N0M0 G1 Malignant
F1 61 F 56 Uterus Endometrioid adenocarcinoma 2–3 Ib T1bN0M0 Malignant
F2 62 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F3 63 F 68 Uterus Endometrioid adenocarcinoma with necrosis (sparse) 3 Ib T1bN0M0 Malignant
F4 64 F 48 Uterus Endometrioid adenocarcinoma with necrosis 3 III T3N0M0 Malignant
F5 65 F 74 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F6 66 F 44 Uterus Endometrioid adenocarcinoma with necrosis (sparse) 3 Ib T1bN0M0 Malignant
F7 67 F 58 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
F8 68 F 35 Uterus Endometrioid adenocarcinoma 3 IIIa T3N0M0 Malignant
F9 69 F 67 Uterus Adenosquamous carcinoma – IIa T2aN0M0 Malignant
F10 70 F 54 Uterus Carcinosarcoma – Ib T1bN0M0 Malignant
F11 71 F 26 Uterus Low grade endometrial stromal sarcoma – IB T2N0M0 G1 Malignant
F12 72 F 60 Uterus Malignant mixed Mullerian Tumor – IB T2N0M0 G1 Malignant
G1 73 F 37 Uterus Endometrial polyp – – – Polyp
G2 74 F 52 Uterus Adenomyosis – – – Normal
G3 75 F 49 Uterus Adenomyosis – – – Normal
G4 76 F 49 Uterus Endometrioid simple hyperplasia – – – Hyperplasia
G5 77 F 57 Uterus Endometrioid simple hyperplasia – – – Hyperplasia
G6 78 F 58 Uterus Proliferative endometrium – – – Normal
G7 79 F 42 Uterus Proliferative endometrium – – – Normal
G8 80 F 32 Uterus Proliferative endometrium – – – Normal
G9 81 F 57 Uterus Proliferative endometrium – – – Normal
G10 82 F 18 Uterus Normal endometrium tissue – – – Normal
G11 83 F 21 Uterus Normal endometrium tissue – – – Normal
G12 84 F 21 Uterus Normal endometrium tissue – – – Normal
H1 85 F 37 Uterus Endometrial polyp – – – Polyp
H2 86 F 52 Uterus Adenomyosis – – – Normal
H3 87 F 49 Uterus Adenomyosis – – – Normal
H4 88 F 49 Uterus Endometrioid simple hyperplasia – – – Hyperplasia
H5 89 F 57 Uterus Endometrioid simple hyperplasia – – – Hyperplasia
H6 90 F 58 Uterus Proliferative endometrium – – – Normal
H7 91 F 42 Uterus Proliferative endometrium – – – Normal
H8 92 F 32 Uterus Proliferative endometrium – – – Normal
H9 93 F 57 Uterus Proliferative endometrium – – – Normal
H10 94 F 18 Uterus Normal endometrium tissue – – – Normal
H11 95 F 21 Uterus Normal endometrium tissue – – – Normal
H12 96 F 21 Uterus Normal endometrium tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal